• Safety & Recalls
  • Regulatory Updates
  • Drug Coverage
  • COPD
  • Cardiovascular
  • Obstetrics-Gynecology & Women's Health
  • Ophthalmology
  • Clinical Pharmacology
  • Pediatrics
  • Urology
  • Pharmacy
  • Idiopathic Pulmonary Fibrosis
  • Diabetes and Endocrinology
  • Allergy, Immunology, and ENT
  • Musculoskeletal/Rheumatology
  • Respiratory
  • Psychiatry and Behavioral Health
  • Dermatology
  • Oncology

First-time generic approvals July 2010

Article

Generic drugs approved by FDA (through June 2010): Venlafaxine hydrochloride extended-release capsules, Meropenem for injection, Adapalene 0.1% gel, Aztreonam for injection, Oxaliplatin for injection

Venlafaxine hydrochloride extended-release capsules (equiv to Effexor XR) in 37.5-mg, 75-mg, and 150-mg strengths

TEVA

Meropenem for injection (equiv to Merrem) in 500-mg and 1-g vials

Adapalene 0.1% gel (equiv to Differin)

TEVA

Aztreonam for injection (equiv to Azactam) in single-dose vials of 1 g, 20 mL and 2 g, 30 mL

APP PHARMACEUTICALS

Oxaliplatin for injection (lyophilized) (equiv to Eloxatin), 50 mg and 100 mg

APP PHARMACEUTICALS

Related Content
© 2024 MJH Life Sciences

All rights reserved.